Real-world effectiveness of lenvatinib monotherapy among previously treated unresectable hepatocellular carcinoma patients in United States clinical practices.

被引：0
|
作者：
Singal, Amit G.
Nagar, Saurabh P.
Hitchens, Abigail
Iyer, Shrividya
机构：
[1] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA
[2] RTI Hlth Solut, Res Triangle Pk, NC USA
[3] RTI Int, Res Triangle Pk, NC USA
[4] Eisai Inc, Woodcliff Lake, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e16129
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16129
引用
收藏
页数：3
相关论文
共 50 条
  • [21] REAL-WORLD TREATMENT PATTERNS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA IN THE UNITED STATES
    Dayyani, Farshid
    Mhatre, Shivani
    Ferro, Ana
    Lawrance, Marcus
    Gaillard, Vincent
    Morse, Michael
    HEPATOLOGY, 2020, 72 : 650A - 651A
  • [22] Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma
    Kuo, Hsin-Yu
    Han, Meng-Zhi
    Liao, Chih-Hsiang
    Lin, Yih-Jyh
    Wang, Chung-Teng
    Chen, Shang-Hung
    Chang, Ting-Tsung
    Chen, Po-Jun
    Lin, Sheng-Hsiang
    Chen, Chiung-Yu
    Chuang, Chiao-Hsiung
    Wu, I-Chin
    Wu, Juei-Seng
    Hong, Tzu-Chun
    Hsieh, Ming-Tsung
    Lee, Yang-Cheng
    Wu, Hung-Tsung
    Tsai, Hong-Ming
    PHARMACEUTICS, 2022, 14 (11)
  • [23] A Real-World Experience on a Chinese Population of Patients With Unresectable Hepatocellular Carcinoma Treated With Nivolumab
    Lee, Shou-Wu
    Yang, Sheng-Shun
    Lee, Teng-Yu
    GASTROENTEROLOGY RESEARCH, 2024, 17 (01) : 15 - 22
  • [24] Real-world clinical characteristics and treatment patterns among people with hepatocellular carcinoma in the United States (US) treated with resection or ablation
    Parikh, Neehar
    Underwood, Dex L.
    Hu, Jenny
    Stirnadel-Farrant, Heide A.
    Kebede, Nehemiah
    Patel, Ravi
    Garcia-Reyes, Kirema
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL)
  • [25] A nationwide multicenter study in patients with unresectable hepatocellular carcinoma treated with lenvatinib in real world practice in Japan.
    Tsuchiya, Kaoru
    Kurosaki, Masayuki
    Kaneko, Shun
    Kimura, Toru
    Marusawa, Hiroyuki
    Arai, Hirotaka
    Abe, Takehiko
    Kimura, Hiroyuki
    Tsuji, Keiji
    Furuta, Koichiro
    Ogawa, Chikara
    Narita, Ryoichi
    Kojima, Yuji
    Akahane, Takehiro
    Uchida, Yasushi
    Yoshida, Hideo
    Kobashi, Haruhiko
    Kusakabe, Atsunori
    Joko, Kouji
    Izumi, Namiki
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [26] Lenvatinib plus pembrolizumab versus lenvatinib in patients with unresectable hepatocellular carcinoma: A real world study.
    Lee, I-Cheng
    Wu, Chi-Jung
    Chen, San-Chi
    Chao, Yee
    Huang, Yi-Hsiang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] ANALYSIS OF FACTORS RELATED TO THE TOLERABILITY OF LENVATINIB FOR PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA IN REAL-WORLD CONDITIONS: A MULTICENTER STUDY
    Taniki, Nobuhito
    Nakamoto, Nobuhiro
    Chu, Po-Sung
    Shiba, Shunsuke
    Tahara, Toshiyuki
    Komatsu, Hirokazu
    Okamura, Yukishige
    Ojiro, Keisuke
    Kikuchi, Masahiro
    Aoki, Yu
    Yamaguchi, Akihiro
    Usui, Shingo
    Kanai, Takanori
    HEPATOLOGY, 2020, 72 : 689A - 689A
  • [28] Real-world study of anlotinib monotherapy and combination therapy for unresectable hepatocellular carcinoma.
    Lei, Yi
    He, Jingchang
    Kang, Shuai
    Liu, Dingli
    Yu, Wenxuan
    Wang, Kunyuan
    Chen, Huaiyu
    Cheng, Yang
    Zhu, Yun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysis
    Hiraoka, Atsushi
    Kumada, Takashi
    Atsukawa, Masanori
    Hirooka, Masashi
    Tsuji, Kunihiko
    Ishikawa, Toru
    Takaguchi, Koichi
    Kariyama, Kazuya
    Itobayashi, Ei
    Tajiri, Kazuto
    Shimada, Noritomo
    Shibata, Hiroshi
    Ochi, Hironori
    Tada, Toshifumi
    Toyoda, Hidenori
    Nouso, Kazuhiro
    Tsutsui, Akemi
    Nagano, Takuya
    Itokawa, Norio
    Hayama, Korenobu
    Imai, Michitaka
    Joko, Kouji
    Koizumi, Yohei
    Hiasa, Yoichi
    Michitaka, Kojiro
    Kudo, Masatoshi
    CANCER MEDICINE, 2019, 8 (08): : 3719 - 3728
  • [30] Predictors of response and survival in patients with unresectable hepatocellular carcinoma treated with nivolumab: real-world experience
    Hsu, Wei-Fan
    Chuang, Po-Heng
    Chen, Cheng-Kuo
    Wang, Hung-Wei
    Tsai, Ming-Hung
    Su, Wen-Pang
    Chen, Hung-Yao
    Yang, Chi-Ying
    Lin, Chun-Che
    Huang, Guan-Tarn
    Lin, Jaw-Town
    Lai, Hsueh-Chou
    Peng, Cheng-Yuan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (12): : 4547 - +
12345